Cooper Companies EBIT

The latest EBIT for COO is $550M as of July 2026. That compares with $720M in the prior-year period — down 24.2% year over year. That is below the Healthcare sector average of $99B. Investors often review this figure alongside Cooper Companies's historical trend and sector peers before judging valuation or financial health.

Over the past year, COO's EBIT moved from $720M to $550M — a 24.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cooper Companies's operating scale or balance-sheet position.

Against Healthcare companies, COO currently prints $550M for EBIT, while the sector average sits near $99B. That is roughly 99.4% below the sector mean. Large gaps often invite a closer look at Cooper Companies's growth, margins, and balance sheet.

A EBIT figure of $550M for COO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $99B. Explore the charts below for those layers of context.

After noting COO's EBIT ($550M), review year-over-year change from $720M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.